Medimetriks Announces that Otsuka Achieved Positive Top-Line Phase 3 Results for MM36 (difamilast) in Japanese Adult and Pediatric Atopic Dermatitis Patients

By In The News
March 26, 2020 in The Headlines

Recommended Posts

In The News

Posted March 26, 2020

- Share

Posted March 26, 2020

FAIRFIELD, N.J., March 26, 2020 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. today announced that its partner, Otsuka Pharmaceuticals Co. Ltd., achieved positive results in two Phase 3 Japanese clinical trials in adult and pediatric patients for MM36 (difamilast), a novel topical,...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219813
2. Jaydee
  16691
3. Kip Powick
  12206
4. deicer
  12179
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.1k
- Total Posts
  
  558.5k

Sign In

Medimetriks Announces that Otsuka Achieved Positive Top-Line Phase 3 Results for MM36 (difamilast) in Japanese Adult and Pediatric Atopic Dermatitis Patients

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support